MX2019003043A - Percutaneous composition based on liquid ammonia, ether, iodine dye, and auxiliary ethyl alcohol for treating muscular and joint pain. - Google Patents

Percutaneous composition based on liquid ammonia, ether, iodine dye, and auxiliary ethyl alcohol for treating muscular and joint pain.

Info

Publication number
MX2019003043A
MX2019003043A MX2019003043A MX2019003043A MX2019003043A MX 2019003043 A MX2019003043 A MX 2019003043A MX 2019003043 A MX2019003043 A MX 2019003043A MX 2019003043 A MX2019003043 A MX 2019003043A MX 2019003043 A MX2019003043 A MX 2019003043A
Authority
MX
Mexico
Prior art keywords
ether
ethyl alcohol
liquid ammonia
auxiliary
composition based
Prior art date
Application number
MX2019003043A
Other languages
Spanish (es)
Inventor
VALENZUELA Elvia CERVANTES
OCHOA Antonio RODRIGUEZ
Original Assignee
VALENZUELA Elvia CERVANTES
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by VALENZUELA Elvia CERVANTES filed Critical VALENZUELA Elvia CERVANTES
Priority to MX2019003043A priority Critical patent/MX2019003043A/en
Publication of MX2019003043A publication Critical patent/MX2019003043A/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention relates to a composition for skin application in liquid form that contains liquid ammonia, ether, iodine dye, and ethyl alcohol formulated in a single dosage unit indicated for the prevention and/or treatment of rheumatic diseases and its main use in the treatment of bone and internal tissue pain. Said composition possess the ability to enhance the permeability of the skin being not toxic, nor irritant, and avoiding producing sensitization on repeated exposures.
MX2019003043A 2019-02-26 2019-02-26 Percutaneous composition based on liquid ammonia, ether, iodine dye, and auxiliary ethyl alcohol for treating muscular and joint pain. MX2019003043A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MX2019003043A MX2019003043A (en) 2019-02-26 2019-02-26 Percutaneous composition based on liquid ammonia, ether, iodine dye, and auxiliary ethyl alcohol for treating muscular and joint pain.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2019003043A MX2019003043A (en) 2019-02-26 2019-02-26 Percutaneous composition based on liquid ammonia, ether, iodine dye, and auxiliary ethyl alcohol for treating muscular and joint pain.

Publications (1)

Publication Number Publication Date
MX2019003043A true MX2019003043A (en) 2020-08-27

Family

ID=83691794

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019003043A MX2019003043A (en) 2019-02-26 2019-02-26 Percutaneous composition based on liquid ammonia, ether, iodine dye, and auxiliary ethyl alcohol for treating muscular and joint pain.

Country Status (1)

Country Link
MX (1) MX2019003043A (en)

Similar Documents

Publication Publication Date Title
EA200701131A1 (en) PREPARATIVE FORM OF CAPSAICINOIDE AND METHODS OF ITS APPLICATION
MX2021007970A (en) 6-oxo-1,6-dihydropyridazine derivative, preparation method therefor and medical use thereof.
MX2020008258A (en) Pediatric niraparib formulations and pediatric treatment methods.
MX2020010603A (en) Hemp extract for treatment of pain in animals.
EA202092154A1 (en) COMBINATION THERAPY
EP1605956A4 (en) Administration of capsaicinoids
MX2022000027A (en) Hemp extract for treatment of pain, cancer and epilepsy in animals.
PH12020500543A1 (en) Nonracemic mixtures and uses thereof
SG10201810404XA (en) Combination comprising a glucocorticoid and edo-s101
RU2017120184A (en) DRUGS TO DELAY THE COURSE OF PARKINSON'S DISEASE
BR112021009616A8 (en) HEALING COMPOSITION COMPRISING ELECTROLYZED WATER AND MASK FOR CUTANEOUS APPLICATION
MX2019003043A (en) Percutaneous composition based on liquid ammonia, ether, iodine dye, and auxiliary ethyl alcohol for treating muscular and joint pain.
JP2019529569A5 (en)
PT1220676E (en) PREVENTION OF COLORCECTAL CANCER
EA202190753A1 (en) OZONIZED OIL COMPOSITION FOR TREATMENT OF TUMOR
WO2014193269A3 (en) Diindolylmethane-based medicinal agent and use thereof to treat influenza and viral respiratory infections
MX2023005462A (en) Macrocyclic compounds and methods of use thereof.
BR112022010733A2 (en) METHODS TO TREAT PAIN
MX2022015074A (en) Azelastine as antiviral treatment.
ZA202104617B (en) Pharmaceutical compound, the method of its making and use as medicinal agent
BR112022000734A2 (en) Method for treating cancer in a patient, use of compound 1, and, compound 1
EA202000298A1 (en) ANTICORONAVIRUS AGENT FOR COMBINATION THERAPY OF COVID-19 (SARS-CoV-2) AND METHOD OF TREATMENT
MX2021002936A (en) Use of low volume plasma exchange for treating the early and middle stages of alzheimer's disease.
PL425832A1 (en) Genistein and its composition to be used in treatment of Alzheimer disease
MX2021008658A (en) Solid forms of ttk inhibitor.